TILs and Anti-PD1 Therapy: An Alternative Combination Therapy for PDL1 Negative Metastatic Cervical Cancer

Table 6

Multivariate analysis (mOS).

Parameters	Hazard ratio	95% confidence interval	value
Infusion of CD8^+ TIL numbers (≥ vs. <)	6.169	(3.001, 12.68)	<0.0001
Infusion of CD8^+ TIL percentage (≥60% vs. <60%)	7.569	(2.992, 19.15)	<0.0001
Infusion of CD8^+PD1^+ TIL percentage (≥10% vs. <10%)	5.321	(3.29, 8.606)	<0.0001
Infusion of CD4^+FoxP3^+ TIL percentage (≥20% vs. <20%)	4.916	(2.939, 8.222)	<0.0001
HPV status (positive vs. negative)	12.74	(2.967, 82.5)	<0.0001
Fever (yes vs. no)	6.314	(2.674, 14.91)	<0.0001